TY  -  
T1  - A pre-specified statistical analysis plan for the VERIFY study : Vildagliptin efficacy in combination with metformin for early treatment of T2DM 
SN  -  /  
UR  - http://hdl.handle.net/10138/327622 
T3  -  
A1  - Matthews, David R.; Paldanius, Päivi M.; Stumvoll, Michael; Han, Jackie; Bader, Giovanni; Chiang, YannTong; Proot, Pieter; Del Prato, Stefano 
A2  -  
PB  -  
Y1  - 2019 
LA  - eng 
AB  - Aims To ensure the integrity of the planned analyses and maximize the clinical utility of the VERIFY study results by describing the detailed concepts behind its statistical analysis plan (SAP) before completion of data collection and study database lock. The SAP will be adhered to for the final primary data analysis of the VERIFY trial. Materials and Methods Vildagliptin efficacy in combination with metformin for early treatment of T2DM (VERIFY) is an ongoing, multicentre, randomized controlled... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - glycaemic durability; randomized controlled trial; statistical analysis plan; type 2 diabetes mellitus; VERIFY study; vildagliptin; HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; INSULIN-RESISTANCE; GLYCEMIC CONTROL; DOUBLE-BLIND; TYPE-2; THERAPY; GLUCOSE; DURABILITY; ADJUSTMENT; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -